Pesquisas alternativas:
developp type » developing type (Expandir a Pesquisa), development type (Expandir a Pesquisa), developed ptypei (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
de developp » se developpe (Expandir a Pesquisa), de developing (Expandir a Pesquisa), le developper (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
developp type » developing type (Expandir a Pesquisa), development type (Expandir a Pesquisa), developed ptypei (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
de developp » se developpe (Expandir a Pesquisa), de developing (Expandir a Pesquisa), le developper (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
101
“... types of drug development questions that are best answered by the comparative oncology approach. We...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
102
Por Smith, R.J
Publicado em 2005
“... are used to develop a prescription to minimize the emergence of drug-resistance for protease-sparing...”Publicado em 2005
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
103
“... adaptor alpha (STRADalpha), and neurofibromatosis type 1 attributed to neurofibromin 1 mutations...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
104
Por Sanjib Bahadur, Kamesh Yadu, Pragya Baghel, Tripti Naurange, Manisha Sahu
Publicado em 2020-08-01
Assuntos:
“...smedds (self micro emulsifying drug delivery system)...”Publicado em 2020-08-01
Obter o texto integral
Artigo
105
Por Russo, Patrizia, Kisialiou, Aliaksei, Lamonaca, Palma, Moroni, Rossana, Prinzi, Giulia, Fini, Massimo
Publicado no Mar Drugs (2015)
“...Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Current approved drugs may...”Publicado no Mar Drugs (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
106
107
“... risk of developing all types of dementia. Cognitive deficits in persons with diabetes mainly affect...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
108
Por Kavanagh, David, McGlasson, Sarah, Jury, Alexa, Williams, Jac, Scolding, Neil, Bellamy, Chris, Gunther, Claudia, Ritchie, Diane, Gale, Daniel P., Kanwar, Yashpal S., Challis, Rachel, Buist, Holly, Overell, James, Weller, Belinda, Flossmann, Oliver, Blunden, Mark, Meyer, Eric P., Krucker, Thomas, Evans, Stephen J. W., Campbell, Iain L., Jackson, Andrew P., Chandran, Siddharthan, Hunt, David P. J.
Publicado no Blood (2016)
“...-dependent drug-induced TMA. We then show that dose-dependent microvascular disease is seen in a transgenic...”Publicado no Blood (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
109
Por Lei, Bai, Nakano, Daisuke, Fan, Yu-Yan, Kitada, Kento, Hitomi, Hirofumi, Kobori, Hiroyuki, Mori, Hirohito, Masaki, Tsutomu, Nishiyama, Akira
Publicado em 2012
“... sufficient renoprotection by AT(1)-receptor antagonist treatment. Type 2 diabetic KKAy mice were treated...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Artigo
110
“.... Precision medicine has been posited as a way to better target disease-related aberrations, but developing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
111
Por Regev, Arie, Seeff, Leonard B., Merz, Michael, Ormarsdottir, Sif, Aithal, Guruprasad P., Gallivan, Jim, Watkins, Paul B.
Publicado em 2014
“... (DILI) during drug development. DILI may resemble almost any type of liver disease, and often presents a...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
112
Por Niu, Ho-Shan, Ku, Po-Ming, Niu, Chiang-Shan, Cheng, Juei-Tang, Lee, Kung-Shing
Publicado no Drug Des Devel Ther (2015)
“...BACKGROUND: The development of new drugs for the treatment of diabetes mellitus (DM) is critically...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
113
“... and prevention for diseases of the developing world. Employing the same focus on well-defined and measurable...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
114
Por Khanna, Chand, Fan, Timothy M., Gorlick, Richard, Helman, Lee J, Kleinerman, Eugenie S., Adamson, Peter C., Houghton, Peter J., Tap, William D., Welch, Danny R., Steeg, Patricia S., Merlino, Glenn, Sorensen, Poul HB, Kirsch, David G., Janeway, Katherine A., Weigel, Brenda, Randall, R. Lor, Meltzer, Paul, Withrow, Stephen J, Paoloni, Melissa, Kaplan, Rosandra N., Teicher, Beverly A., Seibel, Nita L., Üren, Aykut, Patel, Shreyaskumar R., Trent, Jeffrey, Savage, Sharon A., Mirabello, Lisa, Reinke, Denise, Barkauskas, Donald A., Krailo, Mark, Smith, Malcolm A., Bernstein, Mark
Publicado em 2014
“... to be the most common cause of mortality in osteosarcoma patients. A conventional drug development path requiring...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
115
“...Making drug development a more efficient and cost-effective process will have a transformative...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
116
117
Por El-Nabarawi, Mohamed A., Tayel, Saadia A., Soliman, Nadia A., Abo Enin, Hadel A.
Publicado em 2013
“... is to prepare a fixed dose bi therapy using bisoprolol hemifumarate (BH) as antihypertensive drug and buspirone...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
118
“... highlighted ALK as a significant player and target for drug development in cancer. In the present review we...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
119
Por Jiang, Wei, Mautner, Victor-F., Friedrich, Reinhard E., Kluwe, Lan
Publicado no J Clin Neurol (2015)
“... to two cytotoxic drugs (nilotinib and imatinib) were measured by following dose-dependent changes...”Publicado no J Clin Neurol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
120